Bioequivalence of levamlodipine besylate tablets in healthy Chinese subjects: a single-dose and two-period crossover randomized study

Bioequivalence of levamlodipine besylate tablets in healthy Chinese subjects: a single-dose and two-period crossover randomized study

Abstract Background Levamlodipine, a calcium channel blocker, has been show act as a cardiovascular drug. To compare the pharmacokinetic parameters between levamlodipine (test formulation) at a single dose of 5 mg and amlodipine (reference formulation) at a single dose of 10 mg, the bioequivalence s...

Full description

Bibliographic Details
Main Authors: Xin Li, Chenjing Wang, Ting Li, Yanping Liu, Shuqin Liu, Ye Tao, Yaping Ma, Xiaomeng Gao, Yu Cao
Format: Article
Language:English
Published: BMC 2020-11-01
Series:BMC Pharmacology and Toxicology
Subjects:
Levamlodipine
Amlodipine
Bioequivalence
Pharmacokinetics
Online Access:http://link.springer.com/article/10.1186/s40360-020-00459-6

Internet

http://link.springer.com/article/10.1186/s40360-020-00459-6

Similar Items